Kiyomi Ito

5.1k total citations
93 papers, 3.0k citations indexed

About

Kiyomi Ito is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Kiyomi Ito has authored 93 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pharmacology, 45 papers in Oncology and 16 papers in Pharmacology. Recurrent topics in Kiyomi Ito's work include Pharmacogenetics and Drug Metabolism (44 papers), Drug Transport and Resistance Mechanisms (43 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Kiyomi Ito is often cited by papers focused on Pharmacogenetics and Drug Metabolism (44 papers), Drug Transport and Resistance Mechanisms (43 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Kiyomi Ito collaborates with scholars based in Japan, United Kingdom and United States. Kiyomi Ito's co-authors include J. Brian Houston, Yuichi Sugiyama, J. Brian Houston, Hayley S. Brown, Shin‐ichi Kanamitsu, Kiyoshi Sugiyama, Aleksandra Galetin, David Hallifax, Nobutomo Ikarashi and Hiroyuki Kusuhara and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Trends in Pharmacological Sciences and International Journal of Pharmaceutics.

In The Last Decade

Kiyomi Ito

91 papers receiving 2.9k citations

Peers

Countries citing papers authored by Kiyomi Ito

Since Specialization

Citations

This map shows the geographic impact of Kiyomi Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyomi Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyomi Ito more than expected).

Fields of papers citing papers by Kiyomi Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyomi Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyomi Ito. The network helps show where Kiyomi Ito may publish in the future.

Co-authorship network of co-authors of Kiyomi Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyomi Ito. A scholar is included among the top collaborators of Kiyomi Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyomi Ito. Kiyomi Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimation of the Contribution of CYP2C8 and CYP3A4 in Repaglinide Metabolism by Human Liver Microsomes Under Various Buffer Conditions 2017 ·Journal of Pharmaceutical Sciences ·Toshiyuki Kudo, (unknown), (unknown), Ryo Tanaka, (unknown), Kiyomi Ito	7
2	Bridging from Preclinical to Clinical Studies for Tyrosine Kinase Inhibitors Based on Pharmacokinetics/Pharmacodynamics and Toxicokinetics/Toxicodynamics 2011 ·Drug Metabolism and Pharmacokinetics ·(unknown), Motohiro Kato, (unknown), Masaki Ishigai, Toshiyuki Kudo, Kiyomi Ito	22
3	Drug Elution Characteristics of Active Ingredients of Gramalil Fine Granules and Pontal Capsules When Using Simple Suspension Method 2010 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Junichi Iida, (unknown), (unknown), (unknown), (unknown), Nobutomo Ikarashi, Kiyomi Ito, Wataru Ochiai, (unknown), (unknown), Kiyoshi Sugiyama	2
4	A study of the interactions between donepezil and yokukansan, cimetidine, and ketoconazole in rats 2010 ·(unknown), Kiyomi Ito, Nobutomo Ikarashi, Junko Watanabe, (unknown), Yoshio Kase, Kiyoshi Sugiyama	2
5	Use of clearance concepts and modeling techniques in the prediction of metabolic drug–drug interactions 2010 ·Trends in Pharmacological Sciences ·Kiyomi Ito, Yuichi Sugiyama	4
6	The role of renal aquaporin 2 in the alleviation of dehydration associated with diabetic polyuria in KKAy mice 2010 ·Life Sciences ·(unknown), Nobutomo Ikarashi, (unknown), (unknown), Takahiro Toda, Kiyomi Ito, Wataru Ochiai, Kiyoshi Sugiyama	13
7	The Inhibition of Lipase and Glucosidase Activities by Acacia Polyphenol 2010 ·Evidence-based Complementary and Alternative Medicine ·Nobutomo Ikarashi, (unknown), Kiyomi Ito, Wataru Ochiai, Kiyoshi Sugiyama	59
8	Ciprofloxacin Suppresses Cyp3a in Mouse Liver by Reducing Lithocholic Acid-producing Intestinal Flora 2009 ·Drug Metabolism and Pharmacokinetics ·Takahiro Toda, (unknown), Toshiyuki Kudo, Tomoyuki Yoshida, Nobutomo Ikarashi, Kiyomi Ito, Kiyoshi Sugiyama	50
9	Effects of Kampo medicines on Cyp3a and P-glycoprotein activity in vivo 2009 ·Kiyomi Ito, (unknown), Nobutomo Ikarashi, Junko Watanabe, (unknown), Kiyoshi Sugiyama	6
10	Prediction of Human Bioavailability from Human Oral Administration Data and Animal Pharmacokinetic Data Without Data from Intravenous Administration of Drugs in Humans 2009 ·Pharmaceutical Research ·(unknown), Kiyomi Ito, Yoshiaki Kitamura, Kiyoshi Sugiyama, Yuichi Sugiyama	7
11	Comparison of the Pravastatin Original and Generic Drugs in the Simple Suspension Method 2008 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Nobutomo Ikarashi, Kiyomi Ito, (unknown), (unknown), Junichi Iida, Kiyoshi Sugiyama	4
12	Stability of Drugs when Prepared for Tube Administration by Simple Suspension Method 2006 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), (unknown), Nobutomo Ikarashi, Kiyomi Ito, (unknown), (unknown), Kiyoshi Sugiyama	18
13	Database analyses for the prediction of in vivo drug–drug interactions from in vitro data 2004 ·British Journal of Clinical Pharmacology ·Kiyomi Ito, Hayley S. Brown, J. Brian Houston	213
14	Sex Difference in Inhibition of In Vitro Mexazolam Metabolism by Various 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors in Rat Liver Microsomes 2002 ·Drug Metabolism and Disposition ·(unknown), Wataru Takasaki, Toshihiko Ikeda, (unknown), Kiyomi Ito, Yuichi Sugiyama	4
15	Assessment of Systemic Adverse Reactions Induced by Ophthalmic β -Adrenergic Receptor Antagonists 2001 ·Journal of Ocular Pharmacology and Therapeutics ·Yasuhiko Yamada, Risa Takayanagi, (unknown), Kiyomi Ito, Hisakazu Ohtani, Yasufumi Sawada, Tatsuji Iga	24
16	Quantitative Prediction of In Vivo Drug-drug Interactions from In Vitro Data : Effects of Active Transport of Inhibitors into the Liver 2000 ·Shin‐ichi Kanamitsu, (unknown), Kiyomi Ito, Takafumi Iwatsubo, Hiroshi Suzuki, Yuichi Sugiyama	4
17	Role of Pharmacokinetic and Transporter Studies in Drug Design. 1999 ·Journal of the Mass Spectrometry Society of Japan ·Yuichi Sugiyama, Hiroshi Suzuki, Kiyomi Ito	1
18	Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P 4503A4 1999 ·PubMed ·(unknown), Kiyomi Ito, Hiroshi Suzuki, Yuichi Sugiyama	61
19	Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical Approach 1999 ·Pharmaceutical Research ·Kiyomi Ito, Hiroyuki Kusuhara, Yuichi Sugiyama	101
20	PREDICTION OF THE THERAPEUTIC DOSE FOR BENZODIAZEPINE ANXIOLYTICS BASED ON RECEPTOR OCCUPANCY THEORY 1997 ·Biopharmaceutics & Drug Disposition ·Kiyomi Ito, (unknown), Yasuhiko Yamada, (unknown), Yasufumi Sawada, Tatsuji Iga	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact